Skip to main content

"I look forward to working with Pharming to bring leniolisib to APDS patients and studying it further in younger children, as well as other patient populations that may benefit from this precisely targeted therapy."

- Dr. Virgil Dalm
Cookies: This website uses cookies Check the cookies page for more information Accept Decline